Lonza | chemanager-online.com - Chemistry and Life Science

Apr. 17, 2018
News & Opinions
Lonza Dedicates US Gene Therapy Center
Swiss fine chemicals producer and pharmaceutical industry supplier Lonza has opened what it said is the world's largest dedicated cell and gene therapy center at Pearland, near Houston, in the US state of Texas.
Apr. 17, 2018
Topics
Along the Acquisition Trail
For the global specialty chemicals sector, the past two years have been among the most exciting of the young millennium. Many mergers and acquisitions were in the spotlight in 2017 and more have moved into it in 2018. Two of the biggest ...
Mar. 06, 2018
News & Opinions
Lonza Expands in US, Moves Some Production
Swiss fine chemicals producer and pharmaceutical industry supplier Lonza is expanding one production facility in the US while downsizing another. ...
Feb. 28, 2018
Topics
ChemSpec Europe 2018: Online Partnering Program Creates Smart Networking Opportunities
ChemSpec Europe 2018: The Fine and Specialty Chemicals exhibition, taking place 20 – 21 June 2018 at Koelnmesse in Cologne, Germany, is known for being a key marketplace for sourcing and trading of fine and specialty chemicals for a ...
Feb. 27, 2018
Topics
Lonza Adds More Building Blocks for the Healthcare Continuum
Contract development and manufacturing organization (CDMO) Lonza said it exceeded its full-year 2017 guidance. The company reported sales of CHF 5.1 billion. Having closed the acquisition of Capsugel in July 2017, Lonza consolidated the ...
Dec. 19, 2017
News & Opinions
Lonza Implements New Serialization Security Capabilities
Lonza’s finished the implementation of new anti-counterfeiting security capabilities at its integrated development and manufacturing site for biopharmaceutical liquid-filled hard capsules in Edinburgh, UK. According to the company, ...
Oct. 11, 2017
News & Opinions
Lonza Buys Shire US Site
Swiss specialty chemicals company Lonza has acquired Shire’s clinical-stage mammalian manufacturing site in Hayward, California, USA, boosting its cGMP capacity and supplementing existing assets in Slough, UK. Financial details of ...
Sep. 22, 2017
News & Opinions
Catalent Pays $950 Million for Cook Pharmica
US drugmaker Catalent has agreed to buy contract development and manufacturing organization (CDMO) Cook Pharmica for $950 million in cash, boosting its position in the fast-growing biologics area.
Aug. 04, 2017
News & Opinions
Lonza Buys Swiss Micronization Technology Specialist Micro-Macinazione
Swiss fine chemicals and biologics producer Lonza has acquired Micro-Macinazione, a contract manufacturer providing micronization of active ingredients for the pharmaceutical and fine chemical industries based in Monteggio, Switzerland. ...
Jul. 11, 2017
News & Opinions
Lonza Completes Capsugel Acquisition
Lonza has gained all regulatory approvals for its proposed acquisition of Capsugel – the biggest buy in its history – and expects to close the transaction imminently, the company said late last week. ...

12 3 4 5 6 7 8…

Register now!

The latest information directly via newsletter.

GIT Verlag